1887

Abstract

Proteasomal activator gamma (PA28γ), frequently overexpressed in hepatocellular carcinoma, is believed to play important roles in tumourigenesis. However, the underlying mechanism of PA28γ overexpression and its possible roles in hepatitis B virus (HBV) replication are largely unknown. In the present study, we found that hepatitis B virus X protein (HBx) activates PA28γ expression by upregulating p53 levels in human hepatoma cells. The elevated PA28γ levels in turn repressed seven in absentia homologue 1 expression via downregulation of p53 levels, thereby inhibiting ubiquitin-dependent proteasomal degradation of HBx, which ultimately led to upregulation of HBx levels. The correlation among HBx, p53 and PA28γ was exactly reproduced in a 1.2-mer HBV replicon system, mimicking the natural course of HBV infection. In particular, knockdown of either p53 or PA28γ in HepG2 cells downregulated HBx levels and thereby inhibited HBV replication, whereas overexpression of p53 or PA28γ in Hep3B cells upregulated HBx levels, which stimulated HBV replication, indicating that p53 and PA28γ act as activators of HBV replication. In conclusion, HBx levels are upregulated via a positive feedback loop involving p53 and PA28γ to stimulate HBV propagation.

Keyword(s): HBx , hepatitis B virus , p53 , PA28γ and proteasome
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001054
2018-04-03
2019-09-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/99/5/655.html?itemId=/content/journal/jgv/10.1099/jgv.0.001054&mimeType=html&fmt=ahah

References

  1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582–592 [CrossRef][PubMed]
    [Google Scholar]
  2. Lamontagne RJ, Bagga S, Bouchard MJ. Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res 2016;2:163–186 [CrossRef][PubMed]
    [Google Scholar]
  3. Locarnini S, Zoulim F. Molecular genetics of HBV infection. Antivir Ther 2010;15:3–14 [CrossRef][PubMed]
    [Google Scholar]
  4. Liu S, Koh S, Lee C. Hepatitis B virus X protein and hepatocarcinogenesis. Int J Mol Sci 2016;17:940 [CrossRef]
    [Google Scholar]
  5. Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016;64:S84–S101 [CrossRef][PubMed]
    [Google Scholar]
  6. Tsuge M, Hiraga N, Akiyama R, Tanaka S, Matsushita M et al. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. J Gen Virol 2010;91:1854–1864 [CrossRef][PubMed]
    [Google Scholar]
  7. Xu Z, Yen TS, Wu L, Madden CR, Tan W et al. Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol 2002;76:2579–2584 [CrossRef][PubMed]
    [Google Scholar]
  8. Keasler VV, Hodgson AJ, Madden CR, Slagle BL. Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamically-injected mice. Virology 2009;390:122–129 [CrossRef][PubMed]
    [Google Scholar]
  9. Carmona S, Ely A, Crowther C, Moolla N, Salazar FH et al. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol Ther 2006;13:411–421 [CrossRef][PubMed]
    [Google Scholar]
  10. Keasler VV, Hodgson AJ, Madden CR, Slagle BL. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 2007;81:2656–2662 [CrossRef][PubMed]
    [Google Scholar]
  11. Tang H, Delgermaa L, Huang F, Oishi N, Liu L et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 2005;79:5548–5556 [CrossRef][PubMed]
    [Google Scholar]
  12. Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 2001;294:2376–2378 [CrossRef][PubMed]
    [Google Scholar]
  13. Rawat S, Bouchard MJ. The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. J Virol 2015;89:999–1012 [CrossRef][PubMed]
    [Google Scholar]
  14. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996;65:801–847 [CrossRef][PubMed]
    [Google Scholar]
  15. Tomko RJ, Hochstrasser M. Molecular architecture and assembly of the eukaryotic proteasome. Annu Rev Biochem 2013;82:415–445 [CrossRef][PubMed]
    [Google Scholar]
  16. Mao I, Liu J, Li X, Luo H. REGgamma, a proteasome activator and beyond?. Cell Mol Life Sci 2008;65:3971–3980 [CrossRef][PubMed]
    [Google Scholar]
  17. Liu J, Yu G, Zhao Y, Zhao D, Wang Y et al. REGgamma modulates p53 activity by regulating its cellular localization. J Cell Sci 2010;123:4076–4084 [CrossRef][PubMed]
    [Google Scholar]
  18. Zhang Z, Zhang R. Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J 2008;27:852–864 [CrossRef][PubMed]
    [Google Scholar]
  19. Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 2007;26:843–852 [CrossRef][PubMed]
    [Google Scholar]
  20. Li X, Amazit L, Long W, Lonard DM, Monaco JJ et al. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 2007;26:831–842 [CrossRef][PubMed]
    [Google Scholar]
  21. Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y et al. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci USA 2007;104:1661–1666 [CrossRef][PubMed]
    [Google Scholar]
  22. He J, Cui L, Zeng Y, Wang G, Zhou P et al. REGgamma is associated with multiple oncogenic pathways in human cancers. BMC Cancer 2012;12:75 [CrossRef][PubMed]
    [Google Scholar]
  23. Kim S, Lee HS, Ji JH, Cho MY, Yoo YS et al. Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression. J Gen Virol 2015;96:2242–2251 [CrossRef][PubMed]
    [Google Scholar]
  24. Yeom S, Kim SS, Jeong H, Jang KL. Hepatitis B virus X protein activates E3 ubiquitin ligase Siah-1 to control virus propagation via a negative feedback loop. J Gen Virol 2017;98:1774–1784 [CrossRef][PubMed]
    [Google Scholar]
  25. Wang WH, Grégori G, Hullinger RL, Andrisani OM. Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression. Mol Cell Biol 2004;24:10352–10365 [CrossRef][PubMed]
    [Google Scholar]
  26. Wan ZX, Yuan DM, Zhuo YM, Yi X, Zhou J et al. The proteasome activator PA28γ, a negative regulator of p53, is transcriptionally up-regulated by p53. Int J Mol Sci 2014;15:2573–2584 [CrossRef][PubMed]
    [Google Scholar]
  27. Minor MM, Slagle BL. Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system. Viruses 2014;6:4683–4702 [CrossRef][PubMed]
    [Google Scholar]
  28. Wang WH, Hullinger RL, Andrisani OM. Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J Biol Chem 2008;283:25455–25467 [CrossRef][PubMed]
    [Google Scholar]
  29. Kwun HJ, Jang KL. Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Nucleic Acids Res 2004;32:2202–2213 [CrossRef][PubMed]
    [Google Scholar]
  30. Amson RB, Nemani M, Roperch JP, Israeli D, Bougueleret L et al. Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci USA 1996;93:3953–3957 [CrossRef][PubMed]
    [Google Scholar]
  31. Cha MY, Ryu DK, Jung HS, Chang HE, Ryu WS. Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression. J Gen Virol 2009;90:978–986 [CrossRef][PubMed]
    [Google Scholar]
  32. Yan H, Zhong G, Xu G, He W, Jing Z et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012;1:e00049 [CrossRef][PubMed]
    [Google Scholar]
  33. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997;94:14707–14712 [CrossRef][PubMed]
    [Google Scholar]
  34. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995;55:6012–6016[PubMed]
    [Google Scholar]
  35. Feitelson MA, Zhu M, Duan LX, London WT. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993;8:1109–1117[PubMed]
    [Google Scholar]
  36. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR et al. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994;91:2230–2234 [CrossRef][PubMed]
    [Google Scholar]
  37. Lee SG, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Oncogene 2000;19:468–471 [CrossRef][PubMed]
    [Google Scholar]
  38. Ahn JY, Jung EY, Kwun HJ, Lee CW, Sung YC et al. Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53. J Gen Virol 2002;83:2765–2772 [CrossRef][PubMed]
    [Google Scholar]
  39. Jung JK, Kwun HJ, Lee JO, Arora P, Jang KL. Hepatitis B virus X protein differentially affects the ubiquitin-mediated proteasomal degradation of beta-catenin depending on the status of cellular p53. J Gen Virol 2007;88:2144–2154 [CrossRef][PubMed]
    [Google Scholar]
  40. Knoll S, Fürst K, Thomas S, Villanueva Baselga S, Stoll A et al. Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC. Cell Cycle 2011;10:3554–3565 [CrossRef][PubMed]
    [Google Scholar]
  41. Kwak J, Tiwari I, Jang KL. Hepatitis C virus core activates proteasomal activator 28γ expression via upregulation of p53 levels to control virus propagation. J Gen Virol 2017;98:56–67 [CrossRef][PubMed]
    [Google Scholar]
  42. Liu CH, Goldberg AL, Qiu XB. New insights into the role of the ubiquitin-proteasome pathway in the regulation of apoptosis. Chang Gung Med J 2007;30:469–479[PubMed]
    [Google Scholar]
  43. Shirakura M, Murakami K, Ichimura T, Suzuki R, Shimoji T et al. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J Virol 2007;81:1174–1185 [CrossRef][PubMed]
    [Google Scholar]
  44. Zhao J, Wang C, Wang J, Yang X, Diao N et al. E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein. FEBS Lett 2011;585:2943–2950 [CrossRef][PubMed]
    [Google Scholar]
  45. Blanchette P, Branton PE. Manipulation of the ubiquitin-proteasome pathway by small DNA tumor viruses. Virology 2009;384:317–323 [CrossRef][PubMed]
    [Google Scholar]
  46. Edelmann MJ, Kessler BM. Ubiquitin and ubiquitin-like specific proteases targeted by infectious pathogens: Emerging patterns and molecular principles. Biochim Biophys Acta 2008;1782:809–816 [CrossRef][PubMed]
    [Google Scholar]
  47. Randow F, Lehner PJ. Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 2009;11:527–534 [CrossRef][PubMed]
    [Google Scholar]
  48. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495–505 [CrossRef][PubMed]
    [Google Scholar]
  49. Kwak J, Shim JH, Tiwari I, Jang KL. Hepatitis C virus core protein inhibits E6AP expression via DNA methylation to escape from ubiquitin-dependent proteasomal degradation. Cancer Lett 2016;380:59–68 [CrossRef][PubMed]
    [Google Scholar]
  50. Moriishi K, Shoji I, Mori Y, Suzuki R, Suzuki T et al. Involvement of PA28gamma in the propagation of hepatitis C virus. Hepatology 2010;52:411–420 [CrossRef][PubMed]
    [Google Scholar]
  51. Shirakata Y, Koike K. Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J Biol Chem 2003;278:22071–22078 [CrossRef][PubMed]
    [Google Scholar]
  52. Rahmani Z, Huh KW, Lasher R, Siddiqui A. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 2000;74:2840–2846 [CrossRef][PubMed]
    [Google Scholar]
  53. Matsuda Y, Sanpei A, Wakai T, Kubota M, Osawa M et al. Hepatitis B virus X stimulates redox signaling through activation of ataxia telangiectasia mutated kinase. Int J Clin Exp Pathol 2014;7:2032–2043[PubMed]
    [Google Scholar]
  54. Mendy ME, Kaye S, van der Sande M, Rayco-Solon P, Waight PA et al. Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia. Virol J 2006;3:23 [CrossRef][PubMed]
    [Google Scholar]
  55. Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS et al. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 2005;24:6617–6625 [CrossRef][PubMed]
    [Google Scholar]
  56. Ponchel F, Toomes C, Bransfield K, Leong FT, Douglas SH et al. Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol 2003;3:18 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001054
Loading
/content/journal/jgv/10.1099/jgv.0.001054
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error